226 related articles for article (PubMed ID: 7036812)
1. In-vivo acquisition of two different types of aminoglycoside resistance by a single strain of Klebsiella pneumoniae causing severe infection.
Murray BE; Moellering RC
Ann Intern Med; 1982 Feb; 96(2):176-80. PubMed ID: 7036812
[TBL] [Abstract][Full Text] [Related]
2. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
Jotzoff M
Med Klin; 1978 Jun; 73(24):914-7. PubMed ID: 661734
[TBL] [Abstract][Full Text] [Related]
3. Klebsiella neonatal injections: mechanism of broadening aminoglycoside resistance.
Hardy DJ; Legeai RJ; O'Callaghan RJ
Antimicrob Agents Chemother; 1980 Oct; 18(4):542-8. PubMed ID: 7004341
[TBL] [Abstract][Full Text] [Related]
4. Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents.
Almaghrabi R; Clancy CJ; Doi Y; Hao B; Chen L; Shields RK; Press EG; Iovine NM; Townsend BM; Wagener MM; Kreiswirth B; Nguyen MH
Antimicrob Agents Chemother; 2014 Aug; 58(8):4443-51. PubMed ID: 24867988
[TBL] [Abstract][Full Text] [Related]
5. Analysis of neomycin, kanamycin, tobramycin and amikacin resistance mechanisms in gentamicin-resistant isolates of Enterobacteriaceae.
Adwan K; Abu-Hasan N; Al-Asmar H
J Med Microbiol; 1998 Nov; 47(11):1019-21. PubMed ID: 9822302
[TBL] [Abstract][Full Text] [Related]
6. Aminoglycoside resistance: a worldwide perspective.
Young LS; Hindler J
Am J Med; 1986 Jun; 80(6B):15-21. PubMed ID: 3089000
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Activity of Plazomicin Against Carbapenem Resistant Klebsiella pneumoniae Strains.
Demirbas Z; Ozger HS; Suzuk-Yildiz S; Bakkaloglu Z; Dizbay M
Clin Lab; 2022 Jun; 68(6):. PubMed ID: 35704736
[TBL] [Abstract][Full Text] [Related]
8. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
9. Discrepant susceptibility to gentamicin despite amikacin resistance in Klebsiella pneumoniae by VITEK 2 represents false susceptibility associated with the armA 16S rRNA methylase gene.
Ko JH; Baek JY; Peck KR; Cho SY; Ha YE; Kim SH; Huh HJ; Lee NY; Kang CI; Chung DR; Song JH
J Med Microbiol; 2017 Oct; 66(10):1448-1450. PubMed ID: 28893358
[TBL] [Abstract][Full Text] [Related]
10. Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacin.
Tang HJ; Lai CC; Chen CC; Zhang CC; Weng TC; Chiu YH; Toh HS; Chiang SR; Yu WL; Ko WC; Chuang YC
J Microbiol Immunol Infect; 2019 Apr; 52(2):273-281. PubMed ID: 27133391
[TBL] [Abstract][Full Text] [Related]
11. A laboratory assessment of the activities of four aminoglycosides.
Schrire L; Robinson RG; Koornhof HJ
S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
[TBL] [Abstract][Full Text] [Related]
12. Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6')-Ib.
Butler DA; Rana AP; Krapp F; Patel SR; Huang Y; Ozer EA; Hauser AR; Bulman ZP
J Antimicrob Chemother; 2021 Feb; 76(3):671-679. PubMed ID: 33326561
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
Knothe H
J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
[TBL] [Abstract][Full Text] [Related]
14. Review of epidemic aminoglycoside resistance worldwide.
Mayer KH
Am J Med; 1986 Jun; 80(6B):56-64. PubMed ID: 3089005
[TBL] [Abstract][Full Text] [Related]
15. Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin.
Ruiz-Palacios GM; Ponce de Leon S; Sifuentes J; Ponce de Leon S; Calva JJ; Huazano F; Ontiveros C; Ojeda F; Bobadilla M
Am J Med; 1986 Jun; 80(6B):71-5. PubMed ID: 3089006
[TBL] [Abstract][Full Text] [Related]
16. Acquired cross resistance to aminoglycosides in gentamicin-sensitive and gentamicin-resistant strains of enterobacteria.
Al-Asadi MJ; Towner K; Greenwood D
J Med Microbiol; 1981 May; 14(2):171-83. PubMed ID: 7014903
[TBL] [Abstract][Full Text] [Related]
17. Plasmid-specified aminoglycoside-modifying enzymes in clinical isolates of Klebsiella pneumoniae.
Facinelli B; Montanari MP; Calegari L
Eur J Epidemiol; 1985 Mar; 1(1):48-53. PubMed ID: 3021514
[TBL] [Abstract][Full Text] [Related]
18. [Resistance to gentamicin, amikacin and ciprofloxacin among nosocomial isolates of klebsiella pneumoniae subspecie pneumoniae producing extended spectrum beta-lactamases].
Díaz PQ; Bello HT; Domínguez MY; Trabal NF; Mella SM; Zemelman RZ; González GR
Rev Med Chil; 2004 Oct; 132(10):1173-8. PubMed ID: 15631204
[TBL] [Abstract][Full Text] [Related]
19. Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards.
Minshew BH; Pollock HM; Schoenknecht FD; Sherris JC
Antimicrob Agents Chemother; 1977 Dec; 12(6):688-96. PubMed ID: 412464
[TBL] [Abstract][Full Text] [Related]
20. Aminoglycoside resistance in gram-negative bacilli during increased amikacin use. Comparison of experience in 14 United States hospitals with experience in the Minneapolis Veterans Administration Medical Center.
Gerding DN; Larson TA
Am J Med; 1985 Jul; 79(1A):1-7. PubMed ID: 4025364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
